Mushrooms Could Do Magic for Your Immune System – and Your Portfolio

Mushrooms could do magic for your health. In fact, according to researchers form Griffith University, mushrooms have the “ability to activate cell immunity in humans, according to The New Daily. “They do this through their possession of beta-glucans, which humans don’t have. So, when human cells come into contact with this foreign body, the immune system starts to fire up and respond.” That’s creating opportunity for companies such as NeonMind Biosciences Inc. (CSE: NEON)(OTC: NMDBF), United Natural Foods Inc. (NASDAQ:UNFI), New Wave Holdings Corp. (OTC:TRMNF)(CSE:SPOR), Inc. (NASDAQ:AMZN), and HAVN Life Sciences (CSE:HAVN)(OTC:HAVLF).

Mushrooms such as Reishi can help with sleep, anxiety, and depression, according to Teelixir. Lion’s mane can help with memory, according to Healthline. Chaga can help with inflammation for example, according to Best Products. Turkey tail can help support the immune system, and assist with some cancer prevention, says Healthline. Such discoveries could do the trick for investors, too. All as the global market for functional mushrooms was $5.8 billion in 2018, according to market research firm, Mordor Intelligence. Between 2019 and 2024, it’s expected to grow 6.4% a year, according to a CNBC report.

Look at NeonMind Biosciences Inc. (CSE: NEON)(OTC: NMDBF) for example

NeonMind Biosciences Inc., an integrated drug development and wellness company focused on the potential therapeutic uses of psilocybin for treating obesity and weight management conditions, announced today that Health Canada has approved its application for Product License NPN 80111611, the ‘Mindful Blend’ functional mushroom product. Mindful Blend uses 100% plant-based extracts and is formulated to support memory and cognitive function, support the immune system, increase energy, combat stress, and reduce inflammation.

Natural Health Products (NHP) require and undergo rigorous review by Health Canada’s Natural Health Product Directorate (NHPD) to ensure the safety and efficacy of the product. NeonMind's consumer products do not contain any psychoactive or restricted substances.

"The approval from Health Canada allows us to market the proven benefits of our functional mushroom ingredients, differentiating the NeonMind brand as we introduce additional products across the U.S. and Canada. Our consumer products division allows NeonMind to further our reach into the massive functional food market. We continue to meet our strategic operational timelines while also supporting our research and development initiatives," said Rob Tessarolo, President and CEO of NeonMind.

NeonMind's consumer products division includes four dietary supplements in the United States designed to support memory, cognitive function and relieve stress, four mushroom infused coffees in Canada and three additional functional mushroom formulas under NHP review with Health Canada.

According to Data Bridge Market Research, the global Medicinal Mushroom market is expected to reach US$78.7 billion by 2025, from US$38.1 billion in 2017 growing at a CAGR of 9.5% during the forecasted period of 2018 to 2025.

In addition to its consumer products division, NeonMind's pharmaceutical division is engaged in the research and development of drugs and treatments for obesity and obesity related diseases using psychedelic compounds.

Other related developments from around the markets include:

United Natural Foods Inc. announced that in collaboration with solar project developer, Pine Gates Renewables (Pine Gate) as well as U.S. Bank, it is investing in Trent River Solar, a 108.5 megawatt (MW) solar facility located in Jones County, North Carolina. The site, which sits on 640 acres, will contain over 800,000 solar panels and create enough energy to provide power to over 14,000 homes. The solar project will support 300 local and regional jobs and is expected to be completed and placed in service later this month. UNFI will not acquire the energy created at Trent River nor the renewable energy certificates.

New Wave Holdings Corp. announced that it will set forth its plans to aggressively increase its brand presence on Way of Will, a growing health and wellness company known for its natural, aromatherapy-based products, will be putting its plans into motion to grow the brand's presence on The goal is to leverage online sales through the retail giant's prominence as the second-largest e-commerce business in the U.S. by optimizing rich media content and partnering with a third-party logistics company to allow for two-day shipping via Successful implementation of this strategic approach is expected to yield a 350% growth in online sales for Way of Will. Inc. is on pace to spend over $120 billion on supplies and services from businesses in the U.S. in 2021. The purchases are from more than 200,000 companies that operate in communities across the country that help keep Amazon running—from electric vehicle manufacturers to cardboard box producers to construction and engineering firms. The 2021 spending represents an increase of 20% year over year and does not include any of the products Amazon buys and sells to customers in its stores.

HAVN Life Sciences, a biotechnology company pursuing standardized extraction of psychedelic compounds for the creation of APIs that support brain health and enhance the capabilities of the mind, is proud to announce the harvest of its first crop of psilocybin-containing mushrooms from their growing and production facility in Jamaica. Working with its partner, GMP manufacturer P.A. Benjamin in Kingston, the Company will export the harvested psilocybin to Canada where it will be tested for safety and quality control through its lab partner, Delic Labs.

Legal Disclaimer / Except for the historical information presented herein, matters discussed in this article contains forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Winning Media is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. For making specific investment decisions, readers should seek their own advice. NeonMind Biosciences Inc. has paid three thousand five hundred dollars for advertising and marketing services to be distributed by Winning Media. Winning Media is only compensated for its services in the form of cash-based compensation. Winning Media owns ZERO shares of NeonMind Biosciences Inc. Please click here for full disclaimer.

Contact Information:
[email protected]